Cancer Immunotherapy Clinical Trials

October 7, 2021, 1:45 pm -
2:15 pm
Myth-busting patient participation in medical studies

Watch On Demand

Session Description

Clinical trials are essential to bringing promising new therapies to patients, often for the first time or in new combinations with other treatments. What is a clinical trial? What are common misconceptions about clinical trials? How can you access and enroll in a cancer immunotherapy clinical trial? How has the COVID-19 pandemic changed patient participation in cancer clinical trials? These are just few of the questions that Dr. Kunle Odunsi, director of the University of Chicago Medicine Comprehensive Cancer Center, will address during this informative and myth-busting session. Following his talk, you’ll have an opportunity to ask your questions about clinical trials during a live Q&A session.


Kunle Odunsi, M.D., Ph.D.

University of Chicago Medicine Comprehensive Cancer Center

Dr. Kunle Odunsi is the director of the University of Chicago Medicine Comprehensive Cancer Center and dean for oncology at the University of Chicago’s Biological Services Division. He has broad oversight responsibility for all University of Chicago cancer programmatic aspects and sets the organization’s strategic direction which emphasizes research, collaborative cancer discovery and care, outreach and engagement, and development opportunities for early career and promising cancer researchers. His research efforts focus upon the mechanisms of immune recognition in ovarian cancer and the pre-clinical and clinical development of tumor antigen targeted therapies, which are currently being studied in several cancer immunotherapy clinical trials. His contributions to science include the first demonstration of the importance of intraepithelial CD8+ T cell infiltration on favorable outcomes in ovarian cancer patients and the discovery of unique T cell receptors from rare subsets of CD8+ and CD4+ antigen specific T cells. Dr. Odunsi has received many accolades for his work including the Society for Immunotherapy of Cancer Team Science Award in 2020, The Robert, Anne, & Lew Wallace Endowed Chair in Cancer Immunotherapy in 2019, the Ovarian Cancer Research Alliance’s Rosalind Franklin Prize for Excellence in Ovarian Cancer Research in 2019, election to the National Academy of Medicine in 2018, and the Lifetime Achievement in Medicine and Research Award from Medaille College in 2015.

On-Demand Now Available

We are excited to announce that videos from our 2021 Cancer Research Institute (CRI) Virtual Immunotherapy Patient Summit are now available to view on demand.

The on-demand videos can be found on each session page from the agenda.